Anle138b ( DrugBank: anle138b )


1 disease
IDDisease name (Link within this page)Number of trials
6Parkinson disease1

6. Parkinson disease


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04685265
(ClinicalTrials.gov)
December 22, 202017/12/2020A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's DiseaseA Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of anle138b, and to Characterise the Effect of Food of anle138b in Mild to Moderate Parkinson's DiseaseParkinson DiseaseDrug: anle138b;Drug: PlaceboMODAG GmbHAptuit (Verona) Srl, an Evotec Company;Quotient Sciences;Nottingham University Hospitals NHS TrustRecruiting50 Years80 YearsAll48Phase 1United Kingdom